Stokes Family Office’s Sanofi SNY Stock Holding History

Stokes Family Office’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$410K	Sell	8,504 -1,357	-14%	-$63.3K	0.04%	203
2025 Q4	$478K	Buy	+9,861	New	+$489K	0.04%	197
2025 Q2	–	Sell	-3,928	Closed	-$218K	–	245
2025 Q1	$218K	Sell	3,928 -5,707	-59%	-$309K	0.02%	221
2024 Q4	$465K	Buy	+9,635	New	+$490K	0.05%	166
2023 Q4	–	Sell	-11,620	Closed	-$623K	–	322
2023 Q3	$623K	Buy	11,620 +1,751	+18%	+$93.4K	0.07%	167
2023 Q2	$532K	Buy	9,869 +808	+9%	+$43.5K	0.06%	169
2023 Q1	$493K	Buy	9,061 +137	+2%	+$6.66K	0.06%	171
2022 Q4	$432K	Buy	8,924 +2,893	+48%	+$127K	0.06%	181
2022 Q3	$229K	Buy	6,031 +5	+0.1%	+$223	0.03%	237
2022 Q2	$301K	Buy	+6,026	New	+$320K	0.04%	207

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Stokes Family Office's SNY Position: Q1 2026 in Review

Stokes Family Office reduced its Sanofi (SNY) stake by 14% in Q1 2026, selling an estimated $63.3K and leaving 8,504 shares worth $410K. The position accounts for 0.04% of the portfolio, ranked #203.

Stokes Family Office first reported a position in SNY in Q2 2022 and has held it in 10 quarters since. The position peaked at $623K in Q3 2023. 739 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Stokes Family Office held 8,504 shares of Sanofi worth $410K as of Q1 2026.
Stokes Family Office sold 1,357 Sanofi shares in Q1 2026, an estimated $63.3K.
Sanofi made up 0.04% of Stokes Family Office's portfolio in Q1 2026, its #203 holding.
Stokes Family Office first reported a position in Sanofi in Q2 2022 and has held it in 10 quarters since.
Stokes Family Office's Sanofi position peaked at $623K in Q3 2023.
739 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Stokes Family Office's 13F filing for Q1 2026, filed 12 May 2026.